ERSOT
NVCR icon

Employees Retirement System of Texas’s NovoCure NVCR Stock Holding History

Employees Retirement System of Texas’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-29,000
Closed -$2.02M – 579
2022
Q2 		$2.02M Hold
29,000
– – 0.03% 488
2022
Q1 		$2.4M Buy
29,000
+4,000
+16% +$295K 0.03% 497
2021
Q4 		$1.88M Buy
+25,000
New +$2.51M 0.02% 563

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Employees Retirement System of Texas's NVCR Position: Q3 2022 in Review

Employees Retirement System of Texas sold out of NovoCure (NVCR) in Q3 2022, closing a stake of 29,000 shares — an estimated $2.02M sold.

Employees Retirement System of Texas first reported a position in NVCR in Q4 2021 and held it in 3 quarters. The position peaked at $2.4M in Q1 2022. 304 funds tracked by Wall St. Rank hold NVCR as of Q3 2022.

  • Employees Retirement System of Texas reported no remaining NovoCure position as of Q3 2022 after selling out during the quarter.
  • Employees Retirement System of Texas sold 29,000 NovoCure shares in Q3 2022, an estimated $2.02M.
  • Employees Retirement System of Texas first reported a position in NovoCure in Q4 2021 and held it in 3 quarters.
  • Employees Retirement System of Texas's NovoCure position peaked at $2.4M in Q1 2022.
  • 304 funds tracked by Wall St. Rank held NovoCure as of Q3 2022.

Based on Employees Retirement System of Texas's 13F filing for Q3 2022, filed 10 Nov 2022.